Treatment of Recurrent Glioblastoma Multiforme (rGBM) With Antineoplaston AS2-1 in Combination With Targeted Therapy

Cancer and Clinical Oncology
doi 10.5539/cco.v8n1p1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Canadian Center of Science and Education

Related search

Extended Disease-Free Interval of 6 Years in a Recurrent Glioblastoma Multiforme Patient Treated With G207 Oncolytic Viral Therapy

Oncolytic Virotherapy
2015English

High-Dose BCNU With Autologous Bone Marrow Rescue for Recurrent Glioblastoma Multiforme

Journal of Neurosurgery
SurgeryNeurology
1981English

Glioblastoma Multiforme Associated With Klinefelter Syndrome

Neurologia Medico-Chirurgica
SurgeryNeurology
2009English

Targeted Molecular Therapy in Glioblastoma

Journal of Oncology
Oncology
2020English

Glioblastoma Multiforme in a Patient With Isolated Hemimegalencephaly

Journal of Neurological Surgery Reports
2015English

Comprehensive Portrait of Recurrent Glioblastoma Multiforme in Molecular and Clinical Characteristics

Oncotarget
Oncology
2015English

Radiosurgery for Recurrent Glioblastoma Multiforme: A Single Institution Experience

Canadian Journal of Neurological Sciences
MedicineNeurology
2014English

Two Phase II Trials of Temozolomide With Interferon-Α2b (Pegylated and Non-Pegylated) in Patients With Recurrent Glioblastoma Multiforme

British Journal of Cancer
Cancer ResearchOncology
2009English

Combined Salvage Therapies for Recurrent Glioblastoma Multiforme: Treatment Options in Multifocal and Multicentric Patterns of Recurrence

Journal of Cancer Prevention & Current Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy